You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

egf816

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

EGFR-mutant NSCLC Trial in Worldwide (EGF816, trametinib, ribociclib)

Active, not recruiting
  • EGFR-mutant Non-small Cell Lung Cancer
  • EGF816
  • +5 more
  • Toronto, Ontario, Canada
  • +10 more
Dec 5, 2022

Bronchial Tumors Trial in Germany, Spain (EGF816, Trametinib)

Recruiting
  • Bronchial Neoplasms
  • Cologne, Germany
  • +6 more
Nov 2, 2022

Lung Cancer Trial in Boston (EGF816, Gefitinib)

Active, not recruiting
  • Lung Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital
Jan 21, 2022

Advanced NSCLC Trial in Worldwide (EGF816)

Active, not recruiting
Has Results
  • Advanced Non-small Cell Lung Cancer
  • EGF816
  • Boston, Massachusetts
  • +13 more
Oct 21, 2022

Non Small Cell Lung Cancer Trial in Worldwide (EGF816, INC280, Nivolumab)

Terminated
Has Results
  • Non Small Cell Lung Cancer
  • EGF816
  • +2 more
  • Houston, Texas
  • +12 more
Jan 31, 2022

Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma Trial in Worldwide (PDR001, ACZ885, CJM112)

Completed
  • Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma
  • PDR001
  • +4 more
  • Baltimore, Maryland
  • +22 more
Mar 15, 2022